5AA-29696-70588

4 vaccinations 11 coded responses 24 check-ins 10 free-text entries 2 call cases

Sex: Male
Age at first dose: 66+
ZIP prefix: 974 / OR
Registered: 2021-02-27

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2600068 (opens in a new window)	low	10 / 11	9	2 of 5 VAERS symptoms	same dose (4)	FL differs	2022-09-16 / 2022-12-27 / 2023-03-21 received the same day as the last call	case 356261

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-27
Registered in v-safe
2021-02-27
Dose 1 — Pfizer-BioNTech
2021-02-27
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-03-01
Survey response — days 1–6 daily, dose 1
MedDRA: Lethargy — Feeling: Fair · Joint pains, Muscle or body aches

Free text: Lethergy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-03
Survey response — days 1–6 daily, dose 1
MedDRA: Gastrointestinal pain — Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Free text: GI cramps

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-08
Health check-in — day 7, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-15
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-20
Dose 2 — Pfizer-BioNTech
2021-03-22
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness, Pain, Small fibre neuropathy — Feeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Increased pain from small-fiber neuropathy and lightheadedness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-23
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-29
Survey response — day 7, dose 2
MedDRA: Dizziness — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Dizzy, lightheaded

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-05
Survey response — day 14, dose 2
MedDRA: Arthralgia, Fatigue, Myalgia, Poor quality sleep — Feeling: Fair

Free text: Muscle and joint pain extreme fatigue made worse by exercise, wakefulness x3

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-12
Survey response — day 21, dose 2
MedDRA: Arthralgia, Myalgia — Feeling: Fair · Be unable to do your normal daily activities

Free text: Significant Muscle and joint pain worsening over the weekend. I am now 3 weeks out after second shot

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-19
Survey response — day 28, dose 2
MedDRA: Arthralgia, Fatigue, Insomnia, Myalgia — Feeling: Fair

Free text: Persistent muscle and joint pain 24:7 waking at night making exercise difficult as does fatigue cant get enough sleep

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-24
Survey response — day 35, dose 2
MedDRA: Condition aggravated, Fatigue, Feeling abnormal, Myalgia, Osteoarthritis, Pre-existing disease — Feeling: Poor

Free text: Muscle and joint pain plus significant fatigue for four days then two days of improvement followed by another four days of misery and two better. No sign of complete resolution of symptoms. All areas of previous osteoarthritis, neuropathy very painfu

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-01
Survey response — day 42, dose 2
MedDRA: Fatigue, Inflammatory pain, Myalgia — Feeling: Poor · Be unable to do your normal daily activities

Free text: Fluctuating inflammatory pain in muscles, joints and fatigue half day improvement then two of worsening symptoms. Fatigue beginning to retard activity. Now six weeks post injection. I have arthritis and neuropathy and am 74

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-19
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-09-18
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-02-10
Dose 3 — Pfizer-BioNTech
2022-03-20
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-09-16
Dose 4 — Pfizer-BioNTech
2022-09-30
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-07
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-14
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-10-21
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-10-28
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-12-16
Survey response — 3 months, dose 4
MedDRA: Adenovirus infection, Cough, Fatigue, Respiratory tract infection viral, SARS-CoV-2 test negative, Seborrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Viral respiratory infection cough, no fever, PO2 normal, seborrhoea fatigue - NOT COVID probably Adenovirus lasting 4 weeks.

MedDRA releases: 2024-11 · check-in free text available
2022-12-16
Report sent to call center — 3 months, dose 4
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-12-20
Call successful
Not applicable - Accidental Reporting
2023-03-17
Survey response — 6 months, dose 4
MedDRA: Respiratory tract infection viral — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2024-11
2023-03-17
Report sent to call center — 6 months, dose 4
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-03-21
Call successful
Completed over the phone

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-27	Pfizer-BioNTech
2	2021-03-20	Pfizer-BioNTech
3	2022-02-10	Pfizer-BioNTech	No
4	2022-09-16	Pfizer-BioNTech	No

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 1

2021-03-01

Systemic reaction (other): Lethergy

Release 5 — days 1–6 daily, dose 1

2021-03-03

Systemic reaction (other): GI cramps

Release 6 — days 1–6 daily, dose 2

2021-03-22

Systemic reaction (other): Increased pain from small-fiber neuropathy and lightheadedness

Release 6 — day 7, dose 2

2021-03-29

Systemic reaction (other): Dizzy, lightheaded

Release 6 — day 14, dose 2

2021-04-05

Symptoms: Muscle and joint pain extreme fatigue made worse by exercise, wakefulness x3

Release 7 — day 21, dose 2

2021-04-12

Symptoms: Significant Muscle and joint pain worsening over the weekend. I am now 3 weeks out after second shot

Release 7 — day 28, dose 2

2021-04-19

Symptoms: Persistent muscle and joint pain 24:7 waking at night making exercise difficult as does fatigue cant get enough sleep

Release 7 — day 35, dose 2

2021-04-24

Symptoms: Muscle and joint pain plus significant fatigue for four days then two days of improvement followed by another four days of misery and two better. No sign of complete resolution of symptoms. All areas of previous osteoarthritis, neuropathy very painfu cut off by CDC

Release 8 — day 42, dose 2

2021-05-01

Symptoms: Fluctuating inflammatory pain in muscles, joints and fatigue half day improvement then two of worsening symptoms. Fatigue beginning to retard activity. Now six weeks post injection. I have arthritis and neuropathy and am 74

Release 12 — 3 months, dose 4

2022-12-16

Symptoms: Viral respiratory infection cough, no fever, PO2 normal, seborrhoea fatigue - NOT COVID probably Adenovirus lasting 4 weeks.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adenovirus infection	·	·	✓
SD	Arthralgia	✓	✓	✓
SD	Condition aggravated	✓	✓	✓
SD	Cough	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Feeling abnormal	✓	✓	✓
SD	Inflammatory pain	✓	✓	✓
SD	Insomnia	✓	✓	✓
SD	Myalgia	✓	✓	✓
SD	Osteoarthritis	✓	✓	✓
SD	Poor quality sleep	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SD	Respiratory tract infection viral	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Seborrhoea	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Gastrointestinal pain	✓	✓	✓
SRO	Lethargy	✓	✓	✓
SRO	Pain	✓	✓	✓
SRO	Small fibre neuropathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release